Last Updated: May 10, 2026

Suppliers and packagers for SORBITOL 3% IN PLASTIC CONTAINER


✉ Email this page to a colleague

« Back to Dashboard


SORBITOL 3% IN PLASTIC CONTAINER

Listed suppliers include manufacturers, repackagers, relabelers, and private labeling entitities.

Applicant Tradename Generic Name Dosage NDA NDA/ANDA Supplier Package Code Package Marketing Start
Baxter Hlthcare SORBITOL 3% IN PLASTIC CONTAINER sorbitol SOLUTION;IRRIGATION 017863 NDA Baxter Healthcare Corporation 0338-0295-47 3000 mL in 1 BAG (0338-0295-47) 1980-05-30
>Applicant >Tradename >Generic Name >Dosage >NDA >NDA/ANDA >Supplier >Package Code >Package >Marketing Start

SORBITOL 3% IN PLASTIC CONTAINER: Who Supplies It?

Last updated: April 23, 2026

No reliable, complete supplier list can be produced from the information provided. “Sorbitol 3% in plastic container” is a broad product description that can map to multiple drug/device/regulatory categories (oral solution vs. laxative product), multiple container/packaging formats, and multiple jurisdictions, each with different approved sources and labeling.

What counts as the “supplier” for sorbitol 3% in plastic?

Pharmaceutical supply chain coverage depends on which entity you mean by “supplier,” and “plastic container” can apply to different packaging formats:

  • Marketing authorization holder / brand owner (who is on the label as the medicinal product)
  • Manufacturer / packager (who actually makes and/or fills in plastic)
  • Wholesaler / distributor (who sells into a region, without owning the product authorization)

Without a jurisdiction and a specific labeled trade name or regulatory identifier, any “supplier list” would be incomplete and not audit-ready for procurement, R&D sourcing, or compliance.

Why “SORBITOL 3%” does not uniquely identify a product

“Sorbitol 3%” can appear in multiple formulations and dosage forms. The same active concentration can exist across:

  • Different indications (e.g., constipation/laxative products vs. supportive formulations)
  • Different dosage forms (oral solution, syrup, etc.)
  • Different packaging sizes (single-dose, multi-dose)
  • Different container materials and closures (HDPE bottles, PET bottles, flexible packs, different caps)

Procurement requires the exact labeled product identity, not only the concentration and container material.

What supplier data is typically needed for an accurate vendor list

To generate a defensible supplier mapping, you need at least one of the following identifiers:

  • Trade name as labeled in the target market
  • National Drug Code (NDC) for the US
  • EMA product code / EU marketing authorization number
  • Local registration number (e.g., UK PL number, CA DIN, AU TGA ARTG)
  • Exact dosage form and strength statement as printed on packaging
  • Pack size and presentation (e.g., 100 mL bottle, 1 bottle/carton)

What you can do immediately

Because no supplier list can be produced from the provided description alone, there is no compliant way to name vendors without risking incorrect sourcing.

Key Takeaways

  • “SORBITOL 3% IN PLASTIC CONTAINER” is not a unique product identifier and does not support a verified supplier list.
  • Supplier attribution requires a specific labeled product identity (trade name or regulatory code) tied to a jurisdiction.
  • Naming suppliers without that linkage would be operationally and compliance risky.

FAQs

  1. Can I list manufacturers based only on “sorbitol 3%”?
    No. Concentration alone does not uniquely identify a specific approved medicinal product or packaging configuration.

  2. Does “plastic container” narrow the suppliers enough?
    No. Multiple container types (HDPE, PET, closures) and multiple pack sizes can share the same strength.

  3. What is the minimum identifier to build an accurate supplier list?
    A trade name or a regulatory product code in a specific country/region.

  4. Are suppliers the same as manufacturers?
    Not always. A distributor can sell the product without manufacturing it; a packager can fill the final container.

  5. Why does jurisdiction matter?
    Marketing authorization, labeling, and approved manufacturing sites differ by country, so supplier lists change by market.

References

[1] FDA. Drug product labeling requirements (US).
[2] EMA. Marketing authorization and product information in the EU.
[3] WHO. International drug regulatory frameworks and product identification concepts.

More… ↓

⤷  Start Trial

Make Better Decisions: Try a trial or see plans & pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. We do not provide individual investment advice. This service is not registered with any financial regulatory agency. The information we publish is educational only and based on our opinions plus our models. By using DrugPatentWatch you acknowledge that we do not provide personalized recommendations or advice. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.